NLRP3 (Fig. S1B) and mature IL1β levels (Figure 1C) were also elevated in the livers of patients with steatosis and NASH compared with livers from healthy controls. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.